General MedicationsOPHTHALMICGeneric
CROMOLYN SODIUM
CROMOLYN SODIUM
Standard Dose
4%
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview CROMOLYN SODIUM is listed in Drugs@FDA under application 075615 (ANDA).
Marketing status: Discontinued Active ingredient CROMOLYN SODIUM Form and strength SOLUTION/DROPS;OPHTHALMIC - 4% Sponsor APOTEX INC Submission history Latest submission status date: 2001-11-28 00:00:00.
Structured Monograph
Clinical summary
Approval overview CROMOLYN SODIUM is listed in Drugs@FDA under application 075615 (ANDA). Marketing status: Discontinued Active ingredient CROMOLYN SODIUM Form and strength SOLUTION/DROPS;OPHTHALMIC - 4% Sponsor APOTEX INC Submission history Latest submission status date: 2001-11-28 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.